IgA mAb therapeutics (InvivoGen)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameIgA mAb therapeutics (InvivoGen)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibodyBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionTumor necrosis factor modulators
TargetsTumor necrosis factor
Therapy Area/IndicationsArthritis, Rheumatoid
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesInvivogen Therapeutics
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesInvivogen Therapeutics
Active IndicationsN/A
Inactive IndicationsArthritis, Rheumatoid

Other Information

ATC CodeN/A
Related LinksN/A